alphamox 250 capsule blister pack
alphapharm pty ltd - amoxicillin trihydrate, quantity: 288 mg (equivalent: amoxicillin, qty 250 mg) - capsule, hard - excipient ingredients: purified talc; sodium starch glycollate; microcrystalline cellulose; sodium lauryl sulfate; colloidal anhydrous silica; magnesium stearate; titanium dioxide; brilliant blue fcf; purified water; iron oxide yellow; gelatin - treatment of the following infections due to susceptible strains of sensitive organisms. note. therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. however, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. skin and skin structure staphylococcus, non-penicillinase producing; streptococcus; e. coli (see microbiology). respiratory (acute and chronic) h. influenzae; streptococcus; s. pneumoniae; staphylococcus, non-penicillinase producing; e. coli (see microbiology). genitourinary tract (complicated and uncomplicated, acute and chronic) p. mirabilis; s. faecalis; e. coli (see microbiology). gonorrhoea n. gonorrhoea (non-penicillinase producing). prophylaxis of endocarditis amoxycillin may be used for the prophylaxis of bacterial en
keppra
seqirus (nz) ltd - levetiracetam 250mg; ; - film coated tablet - 250 mg - active: levetiracetam 250mg excipient: colloidal silicon dioxide croscarmellose sodium macrogol 6000 magnesium stearate opadry blue 85f20694 - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).
keppra
ms debra wyber - levetiracetam 250mg (s-enantiomer); ; - film coated tablet - 250 mg - active: levetiracetam 250mg (s-enantiomer) excipient: colloidal silicon dioxide magnesium stearate maize starch opadry blue oy-s-30913 povidone purified talc
paroven
haleon new zealand ulc - hydroxyethylrutosides 250mg - capsule - 250 mg - active: hydroxyethylrutosides 250mg excipient: gelatin macrogol 6000
cravit tablet 250 mg
ranbaxy (malaysia) sdn. bhd. - levofloxacin - tablet, film coated - 250 mg - levofloxacin 250 mg
mesasal mesalazine 250 mg enteric coated tablet blister pack
viatris pty ltd - mesalazine, quantity: 250 mg - tablet, enteric coated - excipient ingredients: microcrystalline cellulose; povidone; sodium carbonate; purified talc; titanium dioxide; iron oxide red; colloidal anhydrous silica; calcium stearate; glycine; iron oxide yellow; methacrylic acid copolymer; macrogol 6000; triethyl citrate - indications as at 12 september 1990: treatment of acute inflammatory large bowel disease. maintenance therapy of crohns colitis and ulcerative colitis in patients sensitive to sulfasalazine.
palonosetron dr reddy's palonosetron (as hydrochloride) 250 microgram/5 ml solution for injection vial
dr reddys laboratories australia pty ltd - palonosetron hydrochloride, quantity: 280 microgram (equivalent: palonosetron, qty 250 microgram) - injection, solution - excipient ingredients: mannitol; sodium acetate trihydrate; water for injections; hydrochloric acid; sodium hydroxide - palonosetron injection is indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.
primaxin 250 powder for solution
merck canada inc - imipenem; cilastatin (cilastatin sodium) - powder for solution - 250mg; 250mg - imipenem 250mg; cilastatin (cilastatin sodium) 250mg - carbapenems
clavulin 250 f oral sus powder for suspension
glaxosmithkline inc - amoxicillin (amoxicillin trihydrate); clavulanic acid (clavulanate potassium) - powder for suspension - 250mg; 62.5mg - amoxicillin (amoxicillin trihydrate) 250mg; clavulanic acid (clavulanate potassium) 62.5mg - aminopenicillins
salofalk (r) 5-asa suppositories - 250mg suppository
axcan pharma inc - mesalazine - suppository - 250mg - mesalazine 250mg - anti-inflammatory agents